2024 Q3 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on […]
2024 Q2 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
2024 Q1 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
Overview of AI in Biotech Locust Walk’s Overview of AI in Biotech report discusses how AI has profoundly impacted drug
2023 Year-In-Review Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
2023 Q3 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
2023 Q2 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
Deal Makers of Japan, Volume 3 The Deal Makers of Japan series aims to bridge the gap and offer insight
2023 Q1 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
RNA Therapeutics Landscape Overview Locust Walk views RNA therapeutics in 5 key pillars: RNA Translation Inhibition Protein Expression RNA-Targeting Small